| UniProt ID | DAZ1_HUMAN | |
|---|---|---|
| UniProt AC | Q9NQZ3 | |
| Protein Name | Deleted in azoospermia protein 1 | |
| Gene Name | DAZ1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 744 | |
| Subcellular Localization | Cytoplasm . Nucleus . Predominantly cytoplasmic. Nuclear at some stages of spermatozoide development. Localizes both to the nuclei and cytoplasm of spermatozoide differentiation. Nuclear in fetal gonocytes and in spermatogonial nuclei. It then reloca | |
| Protein Description | RNA-binding protein that plays an essential role in spermatogenesis. May act by binding to the 3'-UTR of mRNAs and regulating their translation. Promotes germ-cell progression to meiosis and formation of haploid germ cells.. | |
| Protein Sequence | MSAANPETPNSTISREASTQSSSAAASQGWVLPEGKIVPNTVFVGGIDARMDETEIGSCFGRYGSVKEVKIITNRTGVSKGYGFVSFVNDVDVQKIVGSQIHFHGKKLKLGPAIRKQKLCARHVQPRPLVVNPPPPPQFQNVWRNPNTETYLQPQITPNPVTQHVQSAANPETPNSTISREASTQSSSAAASQGWVLPEGKIVPNTVFVGGIDARMDETEIGSCFGRYGSVKEVKIITNRTGVSKGYGFVSFVNDVDVQKIVGSQIHFHGKKLKLGPAIRKQKLCARHVQPRPLVVNPPPPPQFQNVWRNPNTETYLQPQITPNPVTQHVQSAANPETPNSTISREASTQSSSAAASQGWVLPEGKIVPNTVFVGGIDARMDETEIGSCFGRYGSVKEVKIITNRTGVSKGYGFVSFVNDVDVQKIVGSQIHFHGKKLKLGPAIRKQKLCARHVQPRPLVVNPPPPPQFQNVWRNPNTETYLQPQITPNPVTQHVQAYSAYPHSPGQVITGCQLLVYNYQEYPTYPDSAFQVTTGYQLPVYNYQPFPAYPRSPFQVTAGYQLPVYNYQAFPAYPNSPFQVATGYQFPVYNYQPFPAYPSSPFQVTAGYQLPVYNYQAFPAYPNSPFQVATGYQFPVYNYQAFPAYPNSPVQVTTGYQLPVYNYQAFPAYPSSPFQVTTGYQLPVYNYQAFPAYPNSAVQVTTGYQFHVYNYQMPPQCPVGEQRRNLWTEAYKWWYLVCLIQRRD | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 36 | Ubiquitination | GWVLPEGKIVPNTVF CEECCCCEECCCEEE | 38.58 | 21906983 | |
| 36 | Ubiquitination | GWVLPEGKIVPNTVF CEECCCCEECCCEEE | 38.58 | 21906983 | |
| 58 | Phosphorylation | MDETEIGSCFGRYGS CCCCCHHHHHCCCCC | 16.37 | 22210691 | |
| 63 | Phosphorylation | IGSCFGRYGSVKEVK HHHHHCCCCCEEEEE | 17.71 | 28857561 | |
| 65 | Phosphorylation | SCFGRYGSVKEVKII HHHCCCCCEEEEEEE | 22.53 | 28857561 | |
| 67 | Ubiquitination | FGRYGSVKEVKIITN HCCCCCEEEEEEEEC | 59.49 | 21906983 | |
| 67 | Ubiquitination | FGRYGSVKEVKIITN HCCCCCEEEEEEEEC | 59.49 | 21906983 | |
| 70 | Ubiquitination | YGSVKEVKIITNRTG CCCEEEEEEEECCCC | 29.49 | - | |
| 73 | Phosphorylation | VKEVKIITNRTGVSK EEEEEEEECCCCCCC | 23.32 | 28857561 | |
| 80 | Ubiquitination | TNRTGVSKGYGFVSF ECCCCCCCCCCEEEE | 54.46 | 21906983 | |
| 80 | Ubiquitination | TNRTGVSKGYGFVSF ECCCCCCCCCCEEEE | 54.46 | 21906983 | |
| 95 | Ubiquitination | VNDVDVQKIVGSQIH ECCEEHHHHCCCEEE | 38.93 | 21906983 | |
| 95 | Ubiquitination | VNDVDVQKIVGSQIH ECCEEHHHHCCCEEE | 38.93 | 21906983 | |
| 106 | Ubiquitination | SQIHFHGKKLKLGPA CEEEECCEECCCCHH | 46.49 | 21906983 | |
| 106 | Ubiquitination | SQIHFHGKKLKLGPA CEEEECCEECCCCHH | 46.49 | 21906983 | |
| 107 | Ubiquitination | QIHFHGKKLKLGPAI EEEECCEECCCCHHH | 56.28 | 21906983 | |
| 107 | Ubiquitination | QIHFHGKKLKLGPAI EEEECCEECCCCHHH | 56.28 | 21906983 | |
| 109 | Ubiquitination | HFHGKKLKLGPAIRK EECCEECCCCHHHHH | 61.35 | - | |
| 116 | Ubiquitination | KLGPAIRKQKLCARH CCCHHHHHHHHCCCC | 45.75 | 21906983 | |
| 116 | Ubiquitination | KLGPAIRKQKLCARH CCCHHHHHHHHCCCC | 45.75 | 21906983 | |
| 118 | Ubiquitination | GPAIRKQKLCARHVQ CHHHHHHHHCCCCCC | 48.87 | 21906983 | |
| 118 | Ubiquitination | GPAIRKQKLCARHVQ CHHHHHHHHCCCCCC | 48.87 | 21906983 | |
| 201 | Ubiquitination | GWVLPEGKIVPNTVF CEECCCCEECCCEEE | 38.58 | 21906983 | |
| 223 | Phosphorylation | MDETEIGSCFGRYGS CCCCCHHHHHCCCCC | 16.37 | 22210691 | |
| 228 | Phosphorylation | IGSCFGRYGSVKEVK HHHHHCCCCCEEEEE | 17.71 | 28857561 | |
| 230 | Phosphorylation | SCFGRYGSVKEVKII HHHCCCCCEEEEEEE | 22.53 | 28857561 | |
| 232 | Ubiquitination | FGRYGSVKEVKIITN HCCCCCEEEEEEEEC | 59.49 | 21906983 | |
| 235 | Ubiquitination | YGSVKEVKIITNRTG CCCEEEEEEEECCCC | 29.49 | - | |
| 238 | Phosphorylation | VKEVKIITNRTGVSK EEEEEEEECCCCCCC | 23.32 | 28857561 | |
| 245 | Ubiquitination | TNRTGVSKGYGFVSF ECCCCCCCCCCEEEE | 54.46 | 21906983 | |
| 260 | Ubiquitination | VNDVDVQKIVGSQIH ECCEEHHHHCCCEEE | 38.93 | 21906983 | |
| 271 | Ubiquitination | SQIHFHGKKLKLGPA CEEEECCEECCCCHH | 46.49 | 21906983 | |
| 272 | Ubiquitination | QIHFHGKKLKLGPAI EEEECCEECCCCHHH | 56.28 | 21906983 | |
| 274 | Ubiquitination | HFHGKKLKLGPAIRK EECCEECCCCHHHHH | 61.35 | - | |
| 281 | Ubiquitination | KLGPAIRKQKLCARH CCCHHHHHHHHCCCC | 45.75 | 21906983 | |
| 283 | Ubiquitination | GPAIRKQKLCARHVQ CHHHHHHHHCCCCCC | 48.87 | 21906983 | |
| 366 | Ubiquitination | GWVLPEGKIVPNTVF CEECCCCEECCCEEE | 38.58 | 21906983 | |
| 388 | Phosphorylation | MDETEIGSCFGRYGS CCCCCHHHHHCCCCC | 16.37 | 22210691 | |
| 393 | Phosphorylation | IGSCFGRYGSVKEVK HHHHHCCCCCEEEEE | 17.71 | 28857561 | |
| 395 | Phosphorylation | SCFGRYGSVKEVKII HHHCCCCCEEEEEEE | 22.53 | 28857561 | |
| 397 | Ubiquitination | FGRYGSVKEVKIITN HCCCCCEEEEEEEEC | 59.49 | 21906983 | |
| 400 | Ubiquitination | YGSVKEVKIITNRTG CCCEEEEEEEECCCC | 29.49 | - | |
| 403 | Phosphorylation | VKEVKIITNRTGVSK EEEEEEEECCCCCCC | 23.32 | 28857561 | |
| 410 | Ubiquitination | TNRTGVSKGYGFVSF ECCCCCCCCCCEEEE | 54.46 | 21906983 | |
| 425 | Ubiquitination | VNDVDVQKIVGSQIH ECCEEHHHHCCCEEE | 38.93 | 21906983 | |
| 436 | Ubiquitination | SQIHFHGKKLKLGPA CEEEECCEECCCCHH | 46.49 | 21906983 | |
| 437 | Ubiquitination | QIHFHGKKLKLGPAI EEEECCEECCCCHHH | 56.28 | 21906983 | |
| 439 | Ubiquitination | HFHGKKLKLGPAIRK EECCEECCCCHHHHH | 61.35 | - | |
| 446 | Ubiquitination | KLGPAIRKQKLCARH CCCHHHHHHHHCCCC | 45.75 | 21906983 | |
| 448 | Ubiquitination | GPAIRKQKLCARHVQ CHHHHHHHHCCCCCC | 48.87 | 2190698 | |
| 560 | Phosphorylation | PFQVTAGYQLPVYNY CCEEEECEECEEEEE | 12.38 | - | |
| 565 | Phosphorylation | AGYQLPVYNYQAFPA ECEECEEEEEEECCC | 13.25 | - | |
| 567 | Phosphorylation | YQLPVYNYQAFPAYP EECEEEEEEECCCCC | 5.41 | - | |
| 613 | Phosphorylation | AGYQLPVYNYQAFPA ECEECEEEEEEECCC | 13.25 | - | |
| 615 | Phosphorylation | YQLPVYNYQAFPAYP EECEEEEEEECCCCC | 5.41 | - | |
| 656 | Phosphorylation | PVQVTTGYQLPVYNY CCEEEECEECEEECE | 12.56 | - | |
| 661 | Phosphorylation | TGYQLPVYNYQAFPA ECEECEEECEECCCC | 13.25 | - | |
| 663 | Phosphorylation | YQLPVYNYQAFPAYP EECEEECEECCCCCC | 5.41 | - | |
| 680 | Phosphorylation | PFQVTTGYQLPVYNY CCEEEECCEEEEEEE | 12.56 | - | |
| 685 | Phosphorylation | TGYQLPVYNYQAFPA ECCEEEEEEEEECCC | 13.25 | - | |
| 687 | Phosphorylation | YQLPVYNYQAFPAYP CEEEEEEEEECCCCC | 5.41 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of DAZ1_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of DAZ1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of DAZ1_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| DAZP1_HUMAN | DAZAP1 | physical | 10857750 | |
| DAZP2_HUMAN | DAZAP2 | physical | 10857750 | |
| DAZ1_HUMAN | DAZ1 | physical | 10857750 | |
| DAZL_HUMAN | DAZL | physical | 10857750 | |
| PUM2_HUMAN | PUM2 | physical | 12511597 | |
| QKI_HUMAN | QKI | physical | 12511597 | |
| BOLL_HUMAN | BOLL | physical | 12511597 | |
| DZIP1_HUMAN | DZIP1 | physical | 12511597 | |
| DZI1L_HUMAN | DZIP1L | physical | 12511597 | |
| DZIP3_HUMAN | DZIP3 | physical | 12511597 | |
| DAZL_HUMAN | DAZL | physical | 12511597 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| 415000 | Spermatogenic failure Y-linked 2 (SPGFY2) | |||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...